CHAPTER 12 Herbal Medicine: Potential for Intoxication and Interactions With Conventional Drugs
The use of herbal remedies for the prevention and treatment of a variety of illnesses in small animals has increased tremendously in recent years. Although most herbal remedies, when used as directed and under the supervision of knowledgeable individuals, are safe, the potential for adverse effects or intoxications certainly exists. Because of inherent toxicity, some herbal remedies should not be used under any circumstance. Also, because nearly all herbal remedies contain multiple biologically active constituents, interaction with conventional drugs is a matter of concern. It is incumbent upon clinicians to be aware of those herbs that can cause intoxication and to be cognizant of potential herb–drug interactions. A number of evidence-based resources are available to assist clinicians in the safe use of herbal remedies.
Both veterinarians and animal owners are expressing an increased interest in learning about and using herbs and other “natural” products to treat medical problems (herbal medicine). The reasons underlying this increased use of herbal and other “alternative” medical modalities in human health have been investigated extensively and are multifactorial (Astin, 1998; Blais, 1997; Elder, 1997). Social, economic and philosophical reasons often underlie the decision by an individual to turn to alternative modalities such as herbal medicine. Unfortunately, similar investigations into the motivation of pet owners to employ such modalities for the treatment of their pets have not been conducted. However, it is likely that the same motivations apply.
Herbal medicine and conventional pharmacology differ in three fundamental ways (Vickers, 1999). First, herbalists use unpurified plant extracts that contain several different constituents in the belief that the various constituents work in coordination, additively, or synergistically (the effect of the whole herb is greater than the summed effects of its individual components). In addition, herbalists believe that toxicity is reduced when the whole herb is used instead of its purified active constituents; this is called “buffering.” Secondly, several herbs are often used together. The theories of additivity, synergism, and buffering are believed to be applicable when herb combinations are employed as well. In conventional medicine, polypharmacy is generally not considered to be desirable because of increased risks of adverse drug reactions or interactions. Finally, herbalists, as well as many other alternative medical practitioners, approach patients in a more “holistic” way than do many conventional medical practitioners, who tend to focus more narrowly on the disease and exclude consideration of other conditions and propensities of the patient.
ACTIVE HERBAL CONSTITUENTS
The following broad classes of active chemical constituents are found in plants: volatile oils, resins, alkaloids, polysaccharides, phenols, glycosides, and fixed oils (Hung, 1998). Volatile oils are odorous plant ingredients. Examples of plants that contain volatile oils include catnip, garlic, and citrus. Ingestion or dermal exposure to volatile oils can result in intoxication. Resins are complex chemical mixtures that can be strong gastrointestinal irritants. Alkaloids are a heterogeneous group of alkaline, organic, and nitrogenous compounds. Often, these compounds are the most pharmacologically active plant constituents. Glycosides are sugar esters that contain a sugar (glycol) and a nonsugar (aglycone). In some cases, the glycosides are not toxic. However, hydrolysis of the glycosides after ingestion can release toxic aglycones. Fixed oils are esters of long-chain fatty acids and alcohols. Herbs that contain fixed oils are often used as emollients, demulcents, and bases for other agents, and, in general, these are the least toxic of the plant constituents.
Many of these plant-derived chemicals are biologically active and, if exposure is of sufficient magnitude, potentially toxic. Numerous case reports in the medical literature document serious and potentially life-threatening adverse effects following human and animal exposure to herbal preparations. It is worth noting that in several instances the incidence of animal intoxication from an herb, herbal preparation, or dietary supplement seems to parallel its popularity (Ooms, 2001; Gwaltney-Brant, 2000). However, it must be noted that, considered as a group, herbal products do not appear to be associated with a higher incidence of serious adverse effects than is associated with ingestion of conventional prescription or over-the-counter (OTC) pharmaceuticals. Serious adverse drug reactions (ADRs) to conventional pharmaceuticals in hospitalized people have been estimated at 6.7% (Lazarou, 1998). An approximately equal incidence of hospital admissions due to ADRs has been reported (Pirmohamed, 2004). A recent study estimated that approximately 25% of all herbal remedy and dietary supplement calls to a regional human poison control center could be classified as ADRs (Yang, 2003). The most common ADRs were associated with zinc (38.2%), echinacea (7.7%), chromium picolinate (6.4%), and witch hazel (6.0%). Only 3 of 233 ADRs were considered to be serious enough to warrant hospitalization. It is likely that ADRs are underreported for both conventional drugs and herbal remedies. Unfortunately, almost no information is available regarding the overall incidence of ADRs with conventional drugs or herbal remedies in veterinary medicine.
Poisoning of an animal might occur in various ways. Use of a remedy that contains a known toxin is one possibility. For example, long-term use of an herbal remedy that contains hepatotoxic pyrrolizidine alkaloids (PAs) may result in liver failure. Pennyroyal oil containing the putative hepatotoxin, pulegone, was responsible for the death of a dog after it was applied dermally to control fleas (Sudekum, 1992). Alternatively, administration of a misidentified plant may result in poisoning. Contamination of commercially prepared herbal remedies with toxic plants has been documented in the medical literature (DeSmet, 1991; Vanherweghem, 1998). Seeds of poison hemlock (Conium maculatum) have been found in anise seed. Recently, plantain sold as a dietary supplement was found to contain cardiac glycosides from Digitalis spp. Just as with traditional prescription medications, pet intoxication following accidental ingestion of an improperly stored remedy may occur. This is particularly true with dogs because of their indiscriminant eating habits. The author was involved in a case in which a miniature poodle ingested several tablets of its owner’s medication containing rauwolfia alkaloids and developed clinical signs within 2 hours of ingestion. Reserpine was detected in the medication and the urine of the dog.
Some herbal remedies, particularly Chinese patent medicines, may contain inorganic contaminants such as arsenic, lead, or mercury or intentionally added pharmaceuticals such as nonsteroidal anti-inflammatories, corticosteroids, caffeine, or sedatives (Ko, 1998). Commonly found natural toxins in Chinese patent medicines include borneol, aconite, toad secretions (Bufo spp, Ch’an Su), mylabris, scorpion, borax, acorus, and strychnine (Strychnos nux-vomica) (Ko, 1998).
Because herbal preparations contain numerous biologically active compounds, the potential exists for diverse drug interactions when they are used in conjunction with conventional pharmaceuticals. In addition, many naturally occurring chemicals found in herbal remedies cause induction of one or more liver P-450 metabolizing enzymes (see Table 12-5). For example, eucalyptus oil induces liver enzyme activity (Blumenthal, 1998a). This can cause altered metabolism of other drugs or chemicals, resulting in enhanced or diminished drug efficacy or toxicity. Coexisting liver or renal disease can alter the metabolism and elimination of herbal constituents, thus predisposing to adverse reactions. Apparent idiosyncratic reactions with herbal remedies have been documented in people. Such reactions might be due to individual differences in drug-metabolizing capacity (Stedman, 2002; Zhou, 2004).
Herb/Supplement | Common Name | Potential Drug Interactions |
---|---|---|
Acacia | Acacia senegal | ↓ intestinal absorption of drugs |
Aceitilla | Bidens pilosa | Insulin and oral hypoglycemic agents |
Ackee apple seed | Blighia sapida | Insulin and oral hypoglycemic agents |
Agar | Gelidium and Gracilaria spp | ↓ intestinal absorption of drugs |
Agrimony | Agrimonia spp | Alkaloidal drugs, anticoagulants, insulin, and oral hypoglycemic agents |
Alfalfa | Medicago sativa | Potential photosensitizing drugs, insulin and oral hypoglycemic agents, lipid-lowering drugs, oral contraceptives/estrogen replacement therapy, vitamin K antagonists |
Aloe gel | Aloe spp | Corticosteroids |
Aloe (dried juice or leaf) | Aloe spp | ↓ intestinal absorption of drugs, antiarrhythmics, corticosteroids, digoxin, diuretics, insulin, and oral hypoglycemic drugs |
Andrographis | Andrographis paniculata | APAP, anticoagulants, antihypertensives, immunosuppressants, insulin, and oral hypoglycemic drugs |
Angelica | Angelica spp | Anticoagulants, potential photosensitizing drugs |
Anise | Pimpinella anisum | Anticoagulants, anticonvulsants, oral contraceptives/estrogen replacement therapy, iron, MAOIs |
Annatto | Bixa orellana | Insulin and oral hypoglycemics |
Arnica | Arnica montana | Anticoagulants |
Ashwagandha | Withania somnifera | Azathioprine, barbiturates, benzodiazepines, CNS depressants, cyclophosphamide, immunosuppressants, insulin and oral hypoglycemic agents, paclitaxel, prednisolone, thyroid replacement therapy |
Astragalus | Astragalus membranaceus | Acyclovir, anticoagulants, cyclophosphamide, immunosuppressants, interferon α1, interleukin-2 |
Autumn crocus | Colchicum autumnale | Fluoxetine, MAOIs |
Bai zhi | Angelica dahurica | Drugs metabolized by CYP2C, CYP3A, and CYP2D1 P-450 enzymes |
Bai zhu | Atractylodes spp | Insulin and oral hypoglycemic agents |
Baikal skullcap | Scutellaria baicalensis | Drugs metabolized by CYP1A1/2 P-450 enzyme, 5-fluorouracil, anticoagulants, benzodiazepines, CNS depressants, cyclophosphamide, insulin, and oral hypoglycemic agents |
Balloon cotton | Asclepias fruticosa | Digoxin or other cardiac glycosides |
Balloon flower | Platycodon grandiflorum | APAP, CNS depressants |
Banana | Musa sapientum | Aspirin, NSAIDs, insulin and oral hypoglycemics, prednisolone, cysteamine, enteral nutrition, insulin, and oral hypoglycemic agents |
Banyan stem | Ficus bengalensis | Insulin and oral hypoglycemic agents |
Barberry | Berberis vulgaris | Drugs metabolized by P-450 enzymes, APAP, α-adrenergic agents, antiarrhythmics, antibiotics, antihypertensives, CNS depressants, cyclophosphamide, cardiac glycosides, general anesthetics, MAOIs, potential photosensitizers, pyrimethamine, and tetracyclines |
Barleria plant | Hygrophilia auriculata | APAP, thioacetamine |
Bay leaf | Laurus nobilis | Drubs metabolized by CYP2B P-450 enzyme |
Bayberry | Myrica cerifera | Corticosteroids |
Belladonna | Atropa belladonna | Anticholinergic drugs |
Betel nut | Areca catechu | Alkaloidal drugs, anticholinergic drugs, cholinergic drugs, procyclidine, and thyroid medications |
Bilberry | Vaccinium myrtillus | Alkaloidal drugs, anticoagulants, insulin, and oral hypoglycemic agents |
Bishop’s weed | Ammi visnaga | Drugs metabolized by P-450 enzymes, antihypertensives, calcium channel blockers, cardiac glycosides, and drugs with potential hepatotoxic and photosensitizing effects |
Bitter melon | Momordica charantia | Insulin and oral hypoglycemics |
Bitter orange | Citrus aurantium | Ephedrine, drugs metabolized by CYP3A4 P-450 enzyme, MAOIs, and potential photosensitizers |
Black currant | Ribes nigrum | Anticoagulants, diuretics |
Black hellebore | Helleborus niger | Cardiac glycosides, quinidine, quinine |
Black pepper | Piper nigrum | Drugs metabolized by P-450 enzymes, coenzyme Q10, barbiturates, NSAIDs, phenytoin, propranolol, methylxanthines, and zoxazolamine |
Black seed | Nigella sativa | Anticoagulants, antihypertensives, cisplatin, and doxorubicin |
Black walnut | Juglans nigra | Alkaloidal drugs |
Blackberry | Rubus fruticosus | Insulin and oral hypoglycemics |
Blazing star | Aletris farinosa | Oxytocin |
Blessed thistle | Cnicus benedictus | Alkaloidal drugs |
Blue cohosh | Caulophyllum thalictroides | Nicotine |
Bogbean | Menyanthes trifoliata | Anticoagulants |
Boldo leaf | Peumus boldus | Drugs metabolized by CYP1A and CYP3A P-450 enzymes, anticoagulants |
Borage | Borago officinalis | Anticoagulants, drugs with hepatotoxic potential, and tamoxifen |
Brahmi | Bacopa monniera | Barbiturates, phenothiazines |
Bromelain | Ananas comosus | Antibiotics, anticoagulants, chemotherapeutic drugs, and cyclosporine |
Buckthorn | Rhamnus frangula | ↓ intestinal absorption of other drugs, corticosteroids, cardiac glycosides, and diuretics |
Bugleweed | Lycopus virginicus | Thyroid drugs |
Burdock | Arctium spp | APAP, insulin, and oral hypoglycemics |
Butcher’s broom | Ruscus aculeatus | α-adrenergic agonists |
Calendula | Calendula officinalis | Acyclovir, CNS depressants |
California poppy | Eschscholzia californica | Analgesics, barbiturates, benzodiazepines, CNS depressants, and MAOIs |
Carrageenan gum | Gigartina mamillosa | ↓ intestinal absorption of other drugs |
Cascara sagrada | Rhamnus purshiana | ↓ intestinal absorption of other drugs |
Castor oil | Ricinus communis | Cardioactive glycosides |
Castor-aralia tree | Kalopanax pictus | Insulin and oral hypoglycemic agents |
Catnip leaf | Nepeta cataria | CNS depressants, barbiturates |
Cat’s claw | Uncaria tomentosa | Drug metabolized by CYP3A4 P-450 enzyme, antihypertensives, chemotherapeutic drugs, immunosuppressive drugs, and NSAIDs |
Cayenne | Capsicum spp | Drugs metabolized by P-450 enzymes, ACE inhibitors, antihypertensives, anticoagulants, aspirin, barbiturates, CNS depressants, ethylmorphine, insulin and oral hypoglycemic agents, MAOIs, NSAIDs, and methylxanthines |
Celery | Apium graveolens | APAP, anticoagulants, drugs with photosensitizing potential, thioacetamine, thyroxine |
Cereus | Selenicereus grandiflorus | Cardiac drugs, cardioactive glycosides, and MAOIs |
Chamomile | Matricaria recutita, Chamomilla recutita | Drugs metabolized by CYP1A2 and CYP3A4 P-450 enzymes, anticoagulants, aspirin, benzodiazepines, CNS depressants, iron, and chemotherapeutic agents |
Chan su | Cardiac glycosides | |
Chaparral | Larrea tridentate | Potentially hepatoxic drugs, MAOIs |
Chard | Beta vulgaris | Insulin and oral hypoglycemic agents |
Chaste tree | Vitex agnus castus | Bromocriptine, dopamine agonists, oral contraceptives, and estrogen replacement therapy |
Chicory | Chichorium intybus | Insulin and oral hypoglycemic agents |
Chinese cinnamon | Cinnamomum aromaticum, C. cassia | Drugs metabolized by P-450 enzymes, metacycline, and tetracycline |
Cinchona bark | Cinchona spp | Anticoagulants, digoxin, mefloquine, and neuromuscular blocking agents |
Cloves | Syzgium aromaticum | Anticoagulants |
Cocoa | Theobroma cacao | APAP, anticoagulants, aspirin, benzodiazepines, cimetidine, clozapine, disulfiram, ephedrine, ergotamine, fluvoxamine, furafylline, grapefruit juice, ibuprofen, idrocilamide, insulin and oral hypoglycemic agents, iron, lithium, MAOIs, methotrexate, methoxsalen, mexiletine, oral contraceptives, phenylpropanolamine, quinolone antibiotics, terbinafine, theophylline, and verapamil |
Cola | Cola nitida | Benzodiazepines, β-adrenergic agonists, methylxanthines, cimetidine, clozapine, disulfiram, ephedrine, furafylline, grapefruit juice, NSAIDs, idrocilamide, insulin and oral hypoglycemic agents, lithium, MAOIs, methotrexate, methoxsalen, mexiletine, oral contraceptives, phenylpropanolamine, propranolol, pseudoephedrine, quinolone antibiotics, terbinafine, theophylline, and verapamil |
Coltsfoot | Tussilago farfara | Alkaloidal drugs, antihypertensives, cardiovascular drugs, and drugs with hepatotoxic potential |
Coriander | Coriandrum sativum | Insulin and oral hypoglycemic agents |
Cranberry | Vaccinium spp | Omeprazole |
Crucifer | Brassica spp | Anticoagulants, drugs metabolized by CYP1A2 P-450 |
Cumin | Cuminum cyminum | Anticoagulants, insulin and oral hypoglycemic agents |
Damiana | Turnera diffusa | Insulin and oral hypoglycemic agents |
Dan shen | Salvia miltiorrhiza | Anticoagulants, cardiac glycosides |
Dandelion | Taraxacum officinale | Drugs metabolized by CYP1A2 and CYP2E P-450 enzymes, anticoagulants, quinolone antibiotics, diuretics, insulin and oral hypoglycemic agents, and lithium |
Devil’s claw | Harpagophytum procumbens | Antiarrhythmics, anticoagulants, antihypertensives, cardiac drugs, and antihypertensives |
Dogbane | Apocynum cannabinum | Cardiac glycosides |
Dong quai | Angelica sinensis | APAP, anticoagulants, oral contraceptives, and estrogen replacement therapy |
Echinacea | Echinacea spp | Drugs metabolized by CYP3A4 P-450 enzymes, chemotherapeutic agents, econazole, and immunosuppressants |
Elder | Sambucus nigra | Insulin and oral hypoglycemic agents |
Elder, American | Sambucus Canadensis | Drugs metabolized by CYP3A4 P-450 enzymes |
Ephedra | Ephedra sinica | Anticonvulsants, antihypertensives, antacids, β blockers, bromocriptine, bupropion, methylxanthines, corticosteroids, cardiac glycosides, diuretics, urine-alkalizing drugs, entacapone, epinephrine, ergotamine, general anesthetics, guanethidine, insulin and oral hypoglycemic agents, linezolid, MAOIs, methyldopa, methylphenidate, methylxanthines, morphine, oxytocin, pseudoephedrine, reserpine, sibutramine, sympathomimetics, stimulants, thyroid replacement therapy, and tricyclic antidepressants |
Eucalyptus | Eucalyptus globules | Drugs metabolized by P-450 enzymes, insulin, and oral hypoglycemic agents |
Evening primrose oil | Oenothera biennis | Anticoagulants, general anesthetics, phenothiazines, and tamoxifen |
Fennel | Foeniculum vulgare | ACE inhibitors, antihypertensives, ciprofloxacin, and diuretics |
Fenugreek | Trigonella foenum-graecum | May alter drug absorption; anticoagulants, insulin, and oral hypoglycemic agents |
Feverfew | Tanacetum parthenium | Anticoagulants, paclitaxel |
Figwort | Scrophularia nodosa | Cardiac glycosides |
Flaxseed | Linum usitatissimum | Alter drug absorption; anticoagulants, insulin and oral hypoglycemic agents, and hormone replacement therapy |
Foxglove | Digitalis spp | Albuterol, amiodarone, aminoglycosides, amphotericin B, antacids, anticoagulants, antiarrhythmics, bleomycin, calcium channel blockers, carmustine, cholestyramine, colestipol, cyclosporine, cytarabine, cardiac glycosides, diuretics, doxorubicin, erythromycin, flecainide, hydroxychloroquine, NSAIDs, itraconazole, macrolide antibiotics, tetracycline, nefazodone, penicillamine, phenytoin, procarbazine, propafenone, quinidine, sulphasalazine, stimulant laxatives, trozodone, verapamil, and vincristine |
Frangipani | Plumeria rubra | Cardiac glycosides |
Fucus | Fucus spp | Altered drug absorption; anticoagulants, diuretics, hyperthyroid medications, iodine-containing drugs, lithium, and thyroid replacement therapy |
γ-Linolenic acid | NA | Anticoagulants, paclitaxel, and tamoxifen |
Garlic | Allium sativum | Drugs metabolized by CYP3A, CYP2B1, CYP2C, CYP2D, and CYP2E1 P-450 enzymes; APAP, antacids, anticoagulants, antihypertensives, doxorubicin, insulin and oral hypoglycemic agents, isoprenaline, and saquinavir |
Genipap | Genipa americana | Drugs metabolized by P-450 enzymes |
Ginger | Zingiber officinale | Anticoagulants, aspirin, chemotherapeutic agents, barbiturates, NSAIDs, insulin and oral hypoglycemic agents, and SSRIs |
Gingko | Gingko biloba | 5-FU, drugs metabolized by CYP3A4 and CYP2D6 P-450 enzymes, anticoagulants, anticonvulsants, cyclosporine, doxorubicin, fluoxetine, general anesthetics, gentamicin, haloperidol, insulin and oral hypoglycemic agents, MAOIs, meclofenoxate, SSRIs, thiazide diuretics, trazodone, and trimipramine |
Ginseng, American | Panax quinquefolius | Cyclophosphamide, doxorubicin, insulin and oral hypoglycemic agents, methotrexate, morphine, oral contraceptives and hormone replacement therapy, paclitaxel, and tamoxifen |
Ginseng, Asian | P. ginseng | Drugs metabolized by CYP2D6 P-450 enzymes, anticoagulants, antihypertensives, anxiolytics, methylxanthines, cardiac glycosides, immunosuppressants, insulin and oral hypoglycemic agents, kanamycin, MAOIs, monomycin, morphine, stimulants, and zidovudine |
Globularia | Globularia alypum | Insulin and oral hypoglycemic agents |
Goat’s rue | Galega officinalis | Anticoagulants and insulin and oral hypoglycemic agents |
Goldenrod | Solidago virguarea | Diuretics and lithium |
Goldenseal | Hydrastis canadensis | Drugs metabolized by CYP3A4 P-450 enzymes, APAP, α-adrenergic agonists, anticoagulants, antiarrhythmics, antihypertensives, CNS depressants, cyclophosphamide, cardiac glycosides, general anesthetics, NSAIDs and other highly protein-bound drugs, isoprenaline, MAOIs, paclitaxel, barbiturates, potential photosensitizers, pyrimethamine, and tetracycline |
Goldthread, coptis | Coptis spp | Chemotherapeutic agents, MAOIs |
Gossypol | Gossypium spp | Drugs metabolized by P-450 enzymes, alkylating agents, cardiac glycosides, diuretics, isoproterenol, barbiturates, stimulant laxatives, and thyroid replacement therapy |
Gotu kola | Centella asiatica | Aspirin, CNS depressants, insulin, and oral hypoglycemic agents |
Grape | Vitis vinifera | Drugs metabolized by P-450 enzymes, APAP, anticoagulants, idarubicin, and cyclophosphamide |
Gravel root | Eupatorium purpureum | Drugs with hepatotoxic potential |
Guar gum | Cyamopsis tetragonolobus | Alter drug absorption, provide enteral nutritional support |
Guarana | Paullinia cupana | APAP, alkaloidal drugs, anticoagulants, aspirin, benzodiazepines, β-adrenergic agonists, cimetidine, clozapine, disulfiram, ephedrine, ergotamine, fluvoxamine, furafylline, NSAIDs, idrocilamide, insulin and oral hypoglycemic agents, lithium, MAOIs, methotrexate, methoxsalen, mexiletine, oral contraceptives, phenylpropanolamine, propranolol, quinolones, terbinafine, methylxanthines, and verapamil |
Guava | Psidium spp | Alkaloidal drugs, insulin, and oral hypoglycemic agents |
Guggul | Commiphora mukul | Diltiazem, propranolol, and thyroid replacement therapy |
Hawthorn | Crataegus oxyacantha | Anticoagulants, antihypertensives, cardiac drugs, CNS depressants, and vasodilators |
Hellebore, American | Veratrum verde | Antihypertensives |
Henbane | Atropa belladonna | Anticholinergic agents |
Hops | Humulus lupulus | Drugs metabolized by CYP2B and CYP1A P-450 enzymes, CNS depressants, oral contraceptives, and hormone replacement therapy |
Horehound | Marrubium vulgare | Antihypertensives, insulin, and oral hypoglycemic agents |
Horse chestnut | Aesculus hippocastanum | Anticoagulants, diuretics, insulin, and oral hypoglycemic agents |
Horseradish | Armoracia rusticana | Thyroid replacement therapy |
Horsetail | Equisetum arvense | Cardiac glycosides, diuretics, and lithium |
Iboga | Tabernanthe iboga | Drugs altering serotonin concentrations in CNS, morphine |
Iceland moss | Cetraria islandica | Alter drug absorption |
Indian snakeroot | Rauvolfia serpentina | Drugs that are substrates of PGP, anticoagulants, antihypertensives, barbiturates, benzodiazepines, CNS depressants, cardiac glycosides, diuretics, general anesthetics, MAOIs, neuroleptics, quinidine, sympathomimetics, and tricyclic antidepressants |
Ivy | Hedera helix | Anticoagulants |
Java tea | Orthosiphon spp | Diuretics |
Jimsonweed | Datura stramonium | Anticholinergic drugs |
Juniper | Juniperus spp | Anticoagulants, insulin, and oral hypoglycemic agents |
Kava | Piper methysticum | Alprazolam, antipsychotics, barbiturates, benzodiazepines, CNS depressants, estrogens, and drugs with hepatotoxic potential |
Kelp | Various species | Anticoagulants, iodine-containing drugs, lithium, and thyroid replacement therapy |
Khat | Catha edulis | Amoxicillin, amphetamines, ampicillin, guanethidine, indoramin, MAOIs, sympathomimetics, and thyroid replacement therapy |
Kudzu | Pueraria lobata | Drugs metabolized by P-450 enzymes |
Lagerstroemia | Lagerstroemia speciosa | Insulin and oral hypoglycemic agents |
Lavender | Lavandula spp | Alkaloidal drugs, barbiturates, and CNS depressants |
Lemon balm | Melissa officinalis | Barbiturates, CNS depressants, and thyroid replacement therapy |
Lemongrass | Cymbopogon citratus | Drugs metabolized by CYP2B P-450 enzymes |
Licorice | Glycyrrhiza glabra | Drugs metabolized by CYP1A2, CYP2B, and CYP3A4 P-450 enzymes; APAP, amiloride, amphotericin B, anticoagulants, antihypertensives, aspirin, cimetidine, corticosteroids, cyclophosphamide, cardiac glycosides, diuretics, oral contraceptives and estrogen replacement therapy, NSAIDs, insulin and oral hypoglycemic agents, MAOIs, spironolactone, stimulant laxatives, and sympathomimetics |
Lily of the valley | Convallaria majalis | Calcium, corticosteroids, cardiac glycosides, quinidine, saluretics, and stimulant laxatives |
LIV 100 | Ayurvedic formulation | Isoniazid, pyrazinamide, and rifampicin |
Long pepper | Piper longum | Drugs metabolized by P-450 enzymes, aspirin, coenzyme Q10, barbiturates, NSAIDs, phenytoin, propranolol, methylxanthines, and zoxazolamine |
Lovage | Levisticum officinale | Anticoagulants |
Lycium | Lycium barbarum | Anticoagulants |
Madagascar periwinkle | Catharanthus roseus | Insulin and oral hypoglycemic agents, cardiac glycosides, vincristine, and vinblastine |
Maté | Ilex paraguariensis | Drugs metabolized by CYP1A2 P-450 enzymes, alkaloidal drugs, APAP, aspirin, benzodiazepines, β-adrenergic agonists, cimetidine, clozapine, disulfiram, ephedrine, ergotamine, fluvoxamine, furafylline, NSAIDs, idrocilamide, insulin and oral hypoglycemic agents, lithium, MAOIs, methotrexate, methoxsalen, mexiletine, oral contraceptives, phenylpropanolamine, quinolones, terbinafine, methylxanthines, and verapamil |
Milk thistle | Silybum marianum | Drugs metabolized by CYP3A4 and CYP2C9 P-450 enzymes, drugs transported by PGP, APAP, aspirin, butyrophenones, cisplatin, cyclosporine, doxorubicin, general anesthetics, insulin and oral hypoglycemic agents, oral contraceptives, phenothiazines, tacrine, and vincristine |
Mistletoe | Viscum album | Chemotherapeutic agents, MAOIs, and radiotherapy |
Motherwort | Leonurus cardiaca | Alkaloidal drugs, anticoagulants, CNS depressants, and cardiac glycosides |
Myrrh | Commiphora molmol | Cyclophosphamide, NSAIDs |
Neem | Azadirachta indica | Insulin and oral hypoglycemic agents, glyburide/glibenclamide, and thyroid replacement therapy |
Nettle, stinging | Urtica dioica folia | Antihypertensives, anticoagulants, CNS depressants, diuretics, insulin, and oral hypoglycemic agents |
Noni | Morinda spp | Oral hypoglycemic agents |
Nutmeg | Myristica fragrans | Drugs metabolized by CYP1A1, CYP1A2, and CYP2E1 P-450 enzymes, flunitrazepam, and MAOIs |
Oats | Avena sativa | Alter drug absorption; morphine and protease inhibitors |
Olive | Olea europaea | Antihypertensives, insulin, and oral hypoglycemic agents |
Onion | Allium cepa | Drugs metabolized by CYP1A, CYP2B, and CYP2E1 P-450 enzymes; anticoagulants, insulin, and oral hypoglycemic agents |
Opium poppy | Papaver somniferum | CNS depressants |
Oregon grape | Berberis aquifolium | Drugs metabolized by P-450 enzymes; APAP, α-adrenergic agonists, antiarrhythmics, anticoagulants, antihypertensives, cyclophosphamide, cardiac glycosides, general anesthetics, MAOIs, potential photosensitizing drugs, pyrimethamine, and tetracycline |
Papaya extract/papain | Carica papaya | Anticoagulants, cyclophosphamide, and diuretics |
Passion flower | Passiflora incarnate | Anticoagulants, anxiolytics, CNS depressants, and barbiturates |
Pau d’Arco | Tabebuia spp | Anticoagulants |
Pennyroyal oil | Mentha pulegium | Drugs with hepatotoxic potential, iron |
Peppermint | Mentha piperita | Drugs metabolized by CYP1A2 and CYP2E P-450 enzymes, drugs ↓ gastric acid secretion, and iron |
Periwinkle | Vinca minor | Cardiac glycosides, vincristine, and vinblastine |
Pheasant’s eye | Adonis vernalis | Albuterol, amiodarone, aminoglycosides, amphotericin B, antacids, antiarrhythmics, bleomycin, calcium, calcium channel blockers, carmustine, cholestyramine, colestipol, cyclophosphamide, cyclosporine, cytarabine, cardiac glycosides, diuretics, doxorubicin, erythromycin, flecainide, glucocorticosteroids, hydroxychloroquine, NSAIDs, itraconazole, laxatives, macrolide antibiotics, tetracycline, nefazodone, penicillamine, phenytoin, procarbazine, propafenone, quinidine, quinine, saluretics, trazodone, verapamil, and vincristine |
Phyllanthus | Phyllanthus spp | Cyclosporine |
Plantain | Plantago spp | Alter drug absorption |
Pleurisy root | Asclepias tuberose | Cardiac glycosides |
Prickly pear | Opuntia spp | Insulin and oral hypoglycemic agents |
Psyllium | Plantago spp | Alter drug absorption; calcium, carbamazepine, cholestyramine, colestid, cardiac glycosides, estrogen, insulin and oral hypoglycemic agents, lithium, and protease inhibitors |
Quercetin | Found in many herbs | Drugs metabolized by CYP1A2 P-450 enzymes, cisplatin, and tamoxifen |
Raspberry | Rubus idaeus | Alkaloidal drugs |
Red clover | Trifolium pretense | Drugs metabolized by CYP3A4 P-450 enzymes, estrogen, and oral contraceptives |
Red sandalwood | Pterocarpus santalinus | Insulin and oral hypoglycemic agents |
Reishi | Ganoderma lucidum | Acyclovir, anticoagulants, antihypertensives, antibiotics, cefazolin, immunosuppressants, insulin and oral hypoglycemic agents, and interferon |
Rhubarb | Rheum officinale | Alter drug absorption; antiarrhythmics, cisplatin, corticosteroids, cardiac glycosides, diuretics, laxatives, and quinidine |
Roman chamomile | Chamaemelum nobile | Drugs metabolized by P-450 enzymes; CNS depressants, insulin, and oral hypoglycemic agents |
Rosemary | Rosmarinus officinalis | Drugs metabolized by CYP1A, CYP2E, and CYP3A P-450 enzymes, PGP substrates, cyclophosphamide, diuretics, insulin and oral hypoglycemic agents, and iron |
Rue | Ruta graveolens | Anticoagulants |
Sacred basil | Ocimum sanctum | Anticoagulants, barbiturates, bromocriptine, doxorubicin, insulin and oral hypoglycemic agents, isoproterenol, and thyroid medications |
Safflower | Carthamus tintorius | Anticoagulants |
Sage | Salvia officinalis | Alkaloidal drugs |
Saiboku-to | Herb mixture | Benzodiazepines, prednisolone |
Sairei-To TJ-114 | Contains glycyrrhizin | Gentamicin |
Sarsaparilla | Smilax spp | Bismuth, cardiac glycosides, and hypnotics |
Sassafras | Sassafras albidum | Drugs metabolized by P-450 enzymes |
Saw palmetto | Serenoa repens, Sabal serrulata | Drugs metabolized by CYP3A4 P-450 enzymes; alkaloidal drugs, anticoagulants, doxazosin, estrogens, finasteride, immunomodulatory drugs, oral contraceptives, and terazosin |
Scopolia | Scopolia carniolica | Amantadine, quinidine, and tricyclic antidepressants |
Scotch broom | Cytisus scoparius | Drugs metabolized by CYP2D6 P-450 enzymes, MAOIs, and sympathomimetics |
Skullcap | Scutellaria lateriflora | CNS depressants |
Senega snakeroot | Polygala senega | Insulin and oral hypoglycemic agents |
Senna | Cassia and Senna spp | Alter intestinal absorption of drugs; antiarrhythmics, corticosteroids, cardiac glycosides, and diuretics |
Shankhapushpi | Herb mixture | Phenytoin |
Shiitake mushrooms | Lentinula edodes | Anticoagulants, chemotherapeutic agents, and didanosine |
Sho-saiko-To TJ-9 | Herb mixture containing glycyrrhizin | Drugs metabolized by CYP3A4 and CYP1A2 P-450 enzymes, insulin and oral hypoglycemic agents, lamivudine, interferon-α, prednisolone, and tolbutamide |
Siberian ginseng | Eleutherococcus senticosis | Drugs metabolized by CYP3A4 P-450 enzymes, barbiturates, CNS depressants, cytarabine, cardiac glycosides, insulin and oral hypoglycemic agents, kanamycin, and monomycin |
Slippery elm | Ulmus spp | Alter drug absorption |
Soybeans | Glycine max | Cisplatin, estrogen, oral hypoglycemic agents, MAOIs, tamoxifen, and thyroid replacement therapy |
Squill | Urginea maritima | Cardiac glycosides, laxatives, quinidine, and saluretics |
Saint John’s Wort | Hypericum perforatum | Anticoagulants, drugs metabolized by CYP3A4 P-450 enzymes, drugs transported by PGP, alprazolam, amsacrine, amitriptyline, amphetamines, methylxanthines, carbamazepine, cyclosporine, dextromethorphan, cardiac glycosides, etoposide, fexofenadine, general anesthetics, L-tryptophan, lithium, MAOIs, mianserin, midazolam, moclobemide, morphine, nevirapine, nifedipine, NNRTIs, nortriptyline, offenfluramine, oral contraceptives, phenprocoumon, potential photosensitizing drugs, protease inhibitors, reserpine, drugs that alter serotonin concentrations, sildenafil, simvastatin, tramadol, SSRIs, tolbutamide, trazodone, tricyclic antidepressants, and venlafaxine |
Stephania | Stephania tetrandra | Anticoagulants, calcium channel blockers |
Strophanthus | Strophanthus spp | Anticoagulants, cardiac glycosides |
Sweet basil | Ocimum basilicum | Drugs metabolized by P-450 enzymes |
Sweet clover | Melilotus officinalis | Anticoagulants |
Tarragon | Artemisia dracunculus | Benzodiazepines |
Tea | Camellia sinensis | Alter drug absorption, drugs metabolized by CYP1A1, CYP1A2, and CYP2B1 P-450 enzymes; anticoagulants, APAP, aspirin, drugs used for atopic dermatitis, benzodiazepines, β-adrenergic agonists, cimetidine, cisplatin, clozapine, disulfiram, doxorubicin, ephedrine, ergotamine, estrogen, fluvoxamine, furafylline, NSAIDs, idrocilamide, insulin and oral hypoglycemic agents, iron, lithium, MAOIs, methotrexate, methoxsalen, metoprolol, mexiletine, oral contraceptives, phenylpropanolamine, propranolol, quinolones, terbinafine, methylxanthines, and verapamil |
Thorny burnet | Sarcopoterium spinosum | Insulin and oral hypoglycemic agents |
Tonka | Dipteryx spp | Anticoagulants |
Trikatu | Herb mixture | Drugs metabolized by P-450 enzymes; aspirin, coenzyme Q10, barbiturates, NSAIDs, isoniazid, phenytoin, propranolol, rifampicin, methylxanthines, and zoxazolamine |
Tumeric | Curcuma longa | Drugs metabolized by CYPA1, CYP1a2, and CYP2B1 P-450 enzymes; anticoagulants, cyclosporine, NSAIDs, and reserpine |
Uva ursi | Arctostaphylos uva ursi | β-Lactam antibiotics, alkaloidal drugs, corticosteroids, and NSAIDs |
Valerian root | Valeriana officinalis | Drugs metabolized by CYP3A4 P-450 enzymes; barbiturates, benzodiazepines, and CNS depressants |
Vervain | Verbena officinalis | Anticoagulants, iron |
Watercress | Nasturtium officinale | Anticoagulants, drugs metabolized by CYP1A1/2 and CYP2E1, APAP, and chlorzoxazone |
Wild carrot | Daucus carota | Antihypertensives |
Willow | Salix spp | Alter drug absorption; salicylates |
Wintergreen | Gaultheria procumbens | Anticoagulants, salicylates |
Witch hazel | Hamamelis virginiana | Alter drug absorption |
Wormwood | Artemisia absinthium | APAP, alkaloidal drugs, and barbiturates |
Yellow oleander | Thevetia peruviana | Cardiac glycosides |
Yi mu cao | Herba leonuri | Drugs metabolized by CYP3A4 P-450 enzymes |
Yin yang huo | Herba eppimedii | Drugs metabolized by CYP3A4 P-450 enzymes |
Yohimbe | Pausinystalia yohimbe | α-Adrenergic antagonists, antihypertensives, β blockers, benzodiazepines, clonidine, CNS stimulants, insulin and oral hypoglycemic agents, levodopa, MAOIs, morphine, phenothiazines, reserpine, SSRIs, sympathomimetics, tricyclic antidepressants, venlafaxine, and xylazine |
Yoko | Paullinia yoko | Drugs metabolized by CYP1A2 P-450 enzymes |
NA, not applicable; APAP, acetaminophen; MAOI, monoamine oxidase inhibitor; CNS, central nervous system; ACE, angiotensin-converting enzyme; SSRI, selective serotonin reuptake inhibitor; 5-FU, 5-fluorouracil; PGP, p-glycoprotein; NNRTI, nonnucleoside reverse transcriptase inhibitors.
From Review of Natural Products, 2000a and b; Herr, 2002.
According to annual surveys of herbs sold in the United States, the most commonly used herbs include coneflower (Echinacea spp), garlic (Allium sativa), ginseng (Panax spp), gingko (Ginkgo biloba), Saint John’s Wort (Hypericum perforatum), saw palmetto (Serenoa repens), goldenseal (Hydrastis canadensis), aloe (Aloe spp), astragalus (Astragalus spp), cayenne (Capsicum spp), bilberry (Vaccinium myrtillus), and cat’s claw (Uncaria tomentosa). Presumably, these herbs are those to which pets are most likely to be exposed. According to the recently published Botanical Safety Handbook, coneflower, saw palmetto, aloe (gel used internally), astragalus, and cayenne (used internally) should be considered safe when used appropriately. Garlic, ginseng, gingko, Saint John’s Wort, goldenseal, aloe (gel used externally, dried juice used externally), and cayenne (used externally) have some restrictions regarding their use (McGuffin, 1997). For example, in humans, garlic should not be used by nursing mothers, and cayenne should not be applied to injured skin or near the eyes. Both gingko and Saint John’s Wort are contraindicated in individuals taking monamine oxidase inhibitors because of the potential for herb–drug interactions. Only insufficient data are available on which clinicians can base a determination regarding the safety of bilberry and cat’s claw, although bilberry is safe enough that it is also used as a food. Of interest is a recent study that listed the most common herb-related calls to a regional human poison control center (Haller, 2002). The most frequent calls, in descending order of frequency, involved Saint John’s Wort, ma huang, echinacea, guarana, ginkgo, ginseng, valerian, tea tree oil, goldenseal, arnica, yohimbe, and kava kava. Not all of the calls could be categorized as ADRs.